Why the study?
Does the availability of NOACs improve adherence to guidelines for prescribing oral anticoagulants in patients with NVAF?
Does the availability of NOACs improve adherence to guidelines for prescribing oral anticoagulants in patients with NVAF?
The introduction of NOACs significantly increased the prescription of guideline-recommended oral anticoagulation and decreased the use of antiplatelet therapy in an elderly, high-risk NVAF population.
No takes yet. Share an insight, caveat, or question.
May increase real-world anticoagulation rates in NVAF; leaves open effects on stroke outcomes.
Ventrella et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: